Americans for Safe Access

JUNE 23, 2023

Some of you may know me through the cannabis industry, but you may not know what brought me here and how Americans for Safe Access changed my family’s lives. We learned online about parents successfully utilizing cannabis treatments; many of them were moving their families to states with medical cannabis programs.

Access 246

Access Treatment Legislation Programs 246

Project CBD

DECEMBER 15, 2021

Abandoned to their fate, desperately ill epileptic children can’t access life-saving cannabis treatments.

Treatment 341

Treatment Access Cannabis 341

NORML

FEBRUARY 13, 2019

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.

Legislation 246

Legislation Access Chronic Pain Marijuana 246

NORML

JUNE 1, 2020

House and Senate lawmakers have approved a series of bills to facilitate patients’ access to medical cannabis products. ” Under the current law, doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .” John Bel Edwards.

Access 211

Access Therapy Legislation Patients 211

Americans for Safe Access

MAY 2, 2024

5 things Everyone Should Know About Cannabis Rescheduling: 1. CANNABIS RESCHEDULING IS A VICTORY FOR PATIENTS BY PATIENTS Cannabis is being rescheduled because of its “currently accepted medical use in treatment in the United States.”

Patients 321

Patients Treatment Programs Access 321

Americans for Safe Access

JUNE 22, 2018

Thanks to the results from recently-permitted scientific studies and the untiring work of cannabis activist groups, more and more people are beginning to accept that cannabis is a successful form of treatment for certain medical conditions. This blog post is crossposted from the Releaf App website.

Treatment 189

Treatment Patients Conditions Cannabis 189

Americans for Safe Access

APRIL 15, 2021

Cannabis was listed as a Schedule I substance, a category for “drugs with no currently accepted medical use and a high potential for abuse”; this is a stricter classification than even raw opium, which is Schedule II. Now, two-thirds of Americans live in states where medical cannabis is legal.

Patients 312

Patients Access Medicine Treatment 312

NORML

MARCH 12, 2020

On March 12th, the House Veterans Affairs Committee (HVAC) passed two separate pieces of legislation pertaining to cannabis policy. The second bill, HR 1647 , known as the Veterans Equal Access Act of 2019, would allow V.A. We must reform our federal cannabis policy.” Presently, V.A.

Marijuana 363

Marijuana Chronic Pain Policy Legislation 363

Americans for Safe Access

APRIL 3, 2025

Crista Eggers is deeply committed to the advocacy and advancement of medical cannabis legalization in Nebraska. After exhausting all medications and available treatment options for Colton, his doctors mentioned medical cannabis treatment.

Advocacy 165

Advocacy Epilepsy Treatment Education 165

NORML

MARCH 11, 2020

As a founding Co-Chair of the Congressional Cannabis Caucus, I am pleased to report to you that my legislation to allow VA doctors to fill out state-legal medical marijuana recommendations is scheduled for a committee vote tomorrow. Congressman Earl Blumenauer (D-OR) speaking a NORML Conference.

Chronic Pain 347

Chronic Pain Marijuana Access Treatment 347

NORML

JULY 12, 2021

The lawsuit, which was filed by a 19-year-old patient who uses cannabis for the treatment of severe epilepsy, argues that the proposed changes will unduly restrict medical cannabis access among patients and will discourage physicians from participating in the program.

Epilepsy 245

Epilepsy Legalization Treatment Patients 245

NORML

APRIL 30, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” ” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. percent in 2016).”

Chronic Pain 355

Chronic Pain Clinical Trials Data Patients 355

NORML

JUNE 15, 2020

“This is common sense legislation that provides physicians, not lawmakers, the ability and discretion to decide what treatment options are best for their patients.". The post Louisiana: Governor Signs Bills Into Law Facilitating Expanded Cannabis Access for Patients appeared first on NORML.

Access 138

Access Patients Law Treatment 138

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. Misleading claims represent both a threat to public health and a violation of consumer access to accurate information.”

CBD 317

CBD Clinical Trials Data Treatment 317

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments.

Treatment 134

Treatment Cannabinoids Blood Pressure Patients 134

NORML

JANUARY 6, 2023

“Cannabis has established efficacy in the treatment of multiple conditions, including chronic pain, and it possesses a safety profile that is either comparable or superior to other controlled substances. The post Study: Chronic Pain Patients Frequently Report Using Cannabis In Place of Opioids appeared first on NORML.

Chronic Pain 235

Chronic Pain Patients Safety Treatment 235

The Cannigma

AUGUST 5, 2022

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

Treatment 141

Treatment Research and Development Therapy Digestion 141

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 271

Law Patients Access Oil 271

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 215

Clinical Trials Chronic Pain Data Treatment 215

Veriheal

SEPTEMBER 29, 2021

For terminally ill patients living out their final days, cannabis can make a world of difference –but they’ve traditionally faced barriers attempting to use the plant medicine in hospital settings. The stack of scientific studies supporting the medical benefits of cannabis grows larger by the year. 28 when Gov.

Access 119

Access Patients Law Treatment 119

Americans for Safe Access

JULY 29, 2020

Oregon is one of the few but growing number of states that have both a medical cannabis program and an adult use (recreational) program, and users of cannabis medicine can be found in either group. Of course having the conversation about cannabis can be complicated, intimidating and nerve racking.

Programs 246

Programs Therapy Medicine Patients 246

Illinois News Joint

JANUARY 9, 2025

The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program. For Illinois News Joint reviews, visit here.

Conditions 105

Conditions Treatment Chronic Pain Epilepsy 105

CannaMD

MARCH 24, 2021

Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS. Why Are Less Teens Treated for Cannabis Use Disorder in Legalized States?

Treatment 105

Treatment Legalization Marijuana Research and Development 105

Veriheal

JANUARY 26, 2024

In April 2023, Delaware became the 22nd state to legalize recreational cannabis with the passing of HB 1 and HB 2. In the meantime, Delaware has been making some serious moves to expand its medical cannabis industry ahead of adult-use sales, which may not begin for another year or more.

Access 110

Access Legalization Marijuana Dispensary 110

NORML

JUNE 11, 2019

Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs. Several peer-reviewed studies now document this trend.

Chronic Pain 202

Chronic Pain Programs Patients Access 202

Veriheal

AUGUST 15, 2022

Cannabis, a plant wrongly accused of causing laziness and tiredness in consumers, could actually offer fatigue-fighting benefits. This is according to a group of researchers from the University of New Mexico (UNM) , who recently teamed up with the creators of the Releaf App to investigate the true link between cannabis use and energy levels.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102

MMJ Recs

DECEMBER 10, 2023

While some states have embraced the therapeutic potential of cannabis and established robust medical marijuana programs, others lag behind, leaving patients without access to a potentially life-changing treatment. Inequality in Medical Cannabis Availability Across the U.S. However, the reality is far from this ideal.

Access 97

Access Marijuana Treatment Patients 97

Cannabis Law Report

AUGUST 20, 2021

The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Many are finding that despite the treatment being approved, they are being denied access in their area.”. How much longer are we going to have to wait?

Access 105

Access Patients Media Treatment 105

Veriheal

APRIL 26, 2023

Brian Mast—recently introduced the Veterans Equal Access Act. If passed by Congress and signed into law, the Veterans Equal Access Act would allow doctors at the U.S. Department of Veterans Affairs (VA) healthcare facilities to issue recommendations for state-legal medical cannabis. How Does Cannabis Benefit Veterans?

Access 105

Access Legislation Cannabis Programs 105

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In part of one of this series, we analyzed the discussions surrounding using cannabis for mental health. In part two, we took a deep look at using cannabis for depression. In part three, we will analyze the available research concerning cannabis and anxiety. Can you use cannabis for anxiety? Cannabis and Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

NORML

MAY 26, 2020

A team of Israeli researchers conducted a randomized placebo-controlled clinical trial to assess the safety and efficacy of a novel, metered-dose cannabis inhaler in 27 patients with chronic pain. Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Clinical Trials 277

Clinical Trials Chronic Pain Cannabinoids Patients 277

Americans for Safe Access

AUGUST 12, 2024

A letter from ASA Founder & President The positive impacts of medical cannabis on patients and the healthcare systems that serve them are profound and far-reaching. Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., and four of the five U.S.

Therapy 261

Therapy Pharmaceutical Treatment Programs 261

NORML

JUNE 10, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments. The CDC’s interest in alternative methods of chronic pain management is likely to be of particular significance to many medical cannabis patients. percent in 2016).”

Chronic Pain 260

Chronic Pain Therapy Patients Topical 260

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Cannabis Law Report

AUGUST 8, 2021

Advocacy group TheraPsil is teaming up with lawyers to pressure the government to grant access and develop regulations. And legal experts think patients are entitled to a reply, and are working alongside advocates to compel the government to give answers and provide access to treatment otherwise prohibited by drug laws.

Access 105

Access Patients Legalization Advocacy 105

Veriheal

JULY 21, 2022

This month, patients will no longer require a medical cannabis card to participate in Virginia’s medical cannabis program. Patients no longer need to register through the Board of Pharmacy in order to legally buy medical cannabis in Virginia. Virginia’s Medical Cannabis Dispensaries Welcome Surge of New Customers .

Access 105

Access Dispensary Patients Programs 105

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025.

Access 105

Access Research and Development Pharmaceutical Therapy 105